Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis)
Abstract Background Idiopathic acute vestibular dysfunction (vestibular neuritis) is the second most common cause of peripheral vertigo after benign paroxysmal positional vertigo (BPPV) and accounts for 7% of the patients who present at outpatient clinics specialising in the treatment of dizziness. The exact aetiology of the condition is unknown and the effects of corticosteroids on […]
Betahistine for Ménière’s disease or syndrome
Abstract Background This is an update of a Cochrane Review first published in The Cochrane Library in Issue 1, 2001 and previously updated in 2008. Ménière’s disease is characterised by attacks of hearing loss, tinnitus and disabling vertigo. Betahistine (Serc®, Betaserc®) is used by many people to reduce the frequency and severity of these attacks […]
Cognitive behavioural therapy for tinnitus
Abstract Background This is an update of a Cochrane Review originally published in Issue 1, 2007 of The Cochrane Library. Tinnitus is an auditory perception that can be described as the experience of sound, in the ear or in the head, in the absence of external acoustic stimulation. Cognitive behavioural therapy (CBT) uses relaxation, cognitive […]
Diuretics for Ménière’s disease or syndrome
Abstract Background This is an update of a review first published in The Cochrane Library Issue 3, 2006. Ménière’s disease is a disorder characterised by hearing loss, tinnitus and disabling vertigo. Diuretics are used to try to reduce the severity and frequency of episodes but there is little evidence behind this treatment. Objectives To assess […]